FDA Approved: FOSAPREPITANT — Supplemental Application (BE Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for fosaprepitant submitted by BE Pharmaceuticals Inc., resulting in an updated label under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

SUPPL AP for FOSAPREPITANT (FOSAPREPITANT)